reports
- Sinan Doganli
CLN CLARIANT AG
NK IMERYS SA
SSAB A SSAB AB CLASS A
EXE EXEL INDUSTRIES SA
MERY MERCIALYS SA
LPE LAURENT-PERRIER SA
BAMNB KONINKLIJKE BAM GROEP NV
BIG BIGBEN INTERACTIVE SA
VIS VISCOFAN S.A.
MMT METROPOLE TELEVISION SA
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
IBG IBERPAPEL GESTION S.A.
COPN COSMO PHARMACEUTICALS NV
FTG111 FLATEXDEGIRO AG
UNI UNICAJA BANCO S.A.
SMCP SMCP SA
HFG HELLOFRESH SE
NACON NACON SASU
ANTIN ANTIN INFRASTRUCTURE PARTNERS
ALLFG ALLFUNDS (UK) LTD
PLNW PLANISWARE
- Sinan Doganli
CLN CLARIANT AG
NK IMERYS SA
SSAB A SSAB AB CLASS A
EXE EXEL INDUSTRIES SA
MERY MERCIALYS SA
LPE LAURENT-PERRIER SA
BAMNB KONINKLIJKE BAM GROEP NV
BIG BIGBEN INTERACTIVE SA
VIS VISCOFAN S.A.
MMT METROPOLE TELEVISION SA
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
IBG IBERPAPEL GESTION S.A.
COPN COSMO PHARMACEUTICALS NV
FTG111 FLATEXDEGIRO AG
UNI UNICAJA BANCO S.A.
SMCP SMCP SA
MVC METROVACESA SA
HFG HELLOFRESH SE
AEDAS AEDAS HOMES SA
NACON NACON SASU
ANTIN ANTIN INFRASTRUCTURE PARTNERS
ALLFG ALLFUNDS (UK) LTD
PLNW PLANISWARE
Chargeurs: 1 director
A director at Chargeurs sold 1,500 shares at 12.760EUR and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
- Baptiste Lebacq
- Klaus Ringel
- Thomas Zlowodzki
TKA THYSSENKRUPP AG
CRI CHARGEURS SA
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
DKSH DKSH HOLDING AG
SSAB A SSAB AB CLASS A
TFI TELEVISION FRANCAISE 1 SA
MERY MERCIALYS SA
SZG SALZGITTER AG
LSS LECTRA SA
VOE VOESTALPINE AG
ACX ACERINOX SA
BAMNB KONINKLIJKE BAM GROEP NV
ERA ERAMET SA
NDA AURUBIS AG
TPS ORANGE POLSKA S.A.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
XIL XILAM ANIMATION SA
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
GLPG GALAPAGOS NV
RIO RIO TINTO PLC
BHP BHP GROUP LTD
PWG PRODWAYS GROUP SA
ALFEN ALFEN NV
AEDAS AEDAS HOMES SA
ALHGR HOFFMANN GREEN CEMENT TECHNOLOGIES SA
FLOW FLOW TRADERS LTD
NCH2 THYSSENKRUPP NUCERA AG & CO.
SCHOTT PHARMA AG
- Baptiste Lebacq
- Klaus Ringel
- Thomas Zlowodzki
TKA THYSSENKRUPP AG
CRI CHARGEURS SA
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
DKSH DKSH HOLDING AG
SSAB A SSAB AB CLASS A
TFI TELEVISION FRANCAISE 1 SA
MERY MERCIALYS SA
SZG SALZGITTER AG
LSS LECTRA SA
VOE VOESTALPINE AG
ACX ACERINOX SA
BAMNB KONINKLIJKE BAM GROEP NV
ERA ERAMET SA
NDA AURUBIS AG
TPS ORANGE POLSKA S.A.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
XIL XILAM ANIMATION SA
A3TV ATRESMEDIA CORPORACION DE MEDIOS DE COMUNICACION SA
GLPG GALAPAGOS NV
RIO RIO TINTO PLC
BHP BHP GROUP LTD
PWG PRODWAYS GROUP SA
ALFEN ALFEN NV
AEDAS AEDAS HOMES SA
ALHGR HOFFMANN GREEN CEMENT TECHNOLOGIES SA
FLOW FLOW TRADERS LTD
NCH2 THYSSENKRUPP NUCERA AG & CO.
SCHOTT PHARMA AG
- Jeremy Garnier
- Jeremy Garnier
- Emira Sagaama
- Juan Ros-Padilla
AMS AMS AG
CRI CHARGEURS SA
EVT EVOTEC SE
FLY SOCIETE FONCIERE LYONNAISE SA
LXS LANXESS AG
BEN BENETEAU SA
KCO KLOECKNER & CO SE
VLS VALNEVA SE
JCQ JACQUET METALS SA
ELG ELMOS SEMICONDUCTOR SE
BAMNB KONINKLIJKE BAM GROEP NV
WIZZ WIZZ AIR HOLDINGS PLC
GN GN STORE NORD A/S
GLB GLANBIA PLC
DEZ DEUTZ AG
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
CPINV CARE PROPERTY INVEST SA
LOG COMPANIA DE DISTRIBUCION INTEGRAL LOGISTA HOLDINGS S.A.
TWEKA TKH GROUP N.V. CERT
SMHN SUESS MICROTEC AG
DIC DIC ASSET AG
ALFEN ALFEN NV
INS INSTONE REAL ESTATE GROUP AG
HAG HENSOLDT AG
COP COMPUGROUP MEDICAL SE & CO. KGAA
KTA KNAUS TABBERT
RWI RENEWI PLC
HGEA HGEARS AG
AF AIR FRANCE - KLM
- Emira Sagaama
- Juan Ros-Padilla
AMS AMS AG
CRI CHARGEURS SA
EVT EVOTEC SE
FLY SOCIETE FONCIERE LYONNAISE SA
LXS LANXESS AG
BEN BENETEAU SA
KCO KLOECKNER & CO SE
VLS VALNEVA SE
JCQ JACQUET METALS SA
ELG ELMOS SEMICONDUCTOR SE
BAMNB KONINKLIJKE BAM GROEP NV
WIZZ WIZZ AIR HOLDINGS PLC
GN GN STORE NORD A/S
GLB GLANBIA PLC
DEZ DEUTZ AG
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
FDR FLUIDRA S.A.
CPINV CARE PROPERTY INVEST SA
LOG COMPANIA DE DISTRIBUCION INTEGRAL LOGISTA HOLDINGS S.A.
TWEKA TKH GROUP N.V. CERT
SMHN SUESS MICROTEC AG
DIC DIC ASSET AG
ALFEN ALFEN NV
INS INSTONE REAL ESTATE GROUP AG
HAG HENSOLDT AG
COP COMPUGROUP MEDICAL SE & CO. KGAA
KTA KNAUS TABBERT
RWI RENEWI PLC
HGEA HGEARS AG
AF AIR FRANCE - KLM
- Jeremy Garnier
Chargeurs : Good Q3 revenues - gradual recovery confirmed and better v...
>Q3 revenues up 11.2% (+10.5% l-f-l) at € 165.3m - Chargeurs’ Q3 revenues, reported this morning, were close to our forecast with growth of 11.2% to € 165.3m (vs € 175m est.). Over nine months on a cumulative basis, revenues came to € 539.6m (vs € 550m est.) reflecting growth of 9.4% (+10.9% l-f-l). Revenues from nearly all the divisions were in line with our expectations, the gap for Museum studio stemming from delayed billing for projects from quarter to quarter bu...
- Jeremy Garnier
Chargeurs : Bon CA T3 2023 - rebond progressif confirmé et meilleure v...
>CA T3 en hausse de 11.2% (+10.5% lfl) à 165.3 M€ - Chargeurs a publié ce matin un CA T3 proche de notre attente en progression de 11.2% à 165.3 M€ (vs 175 M€e). Sur 9 mois cumulés, le CA s’établit à 539.6 M€ (vs 550 M€e) traduisant une croissance de 9.4% (+10.9% lfl). Tous les CA par pôle sont en ligne avec nos attentes, l’écart provient du pôle Museum Studios avec des décalages de facturation de projets d’un trimestre à l’autre mais aucune remise en question de la ...
BioSenic provides third quarter 2024 Business Update
BioSenic provides third quarter 2024 Business Update BioSenic provides third quarter 2024 Business Update BioSenic is actively seeking one or more new assets through a merger or acquisition process Mont-Saint-Guibert, Belgium, October 28, 2024, 7.00 am CEST – Regulated Information - (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases, as well as cell repair, today provides its business update for the third quarter, ended 30 September 2024. Key highlights In July 2024, BioSenic sig...
BioSenic fait le point sur ses activités du troisième trimestre 2024
BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic lance activement la recherche d'un ou de plusieurs nouveaux actifs par le biais d'un processus de fusion ou d'acquisition Mont-Saint-Guibert, Belgique, le 28 octobre 2024 à 07h00 CEST – Information Reglementée - Euronext Bruxelles et Paris : BIOS), la société en phase clinique spécialisée dans les maladies auto-immunes et inflammatoires sévères, ainsi que la réparation cellulaire, fait aujourd’hui un point sur son activité pou...
BioSenic S.A. : Transparency notification received from ABO Infiniu...
BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD. REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, October 7, 2024, 7:00 CEST – (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces that it has received a transparency notification from ABO Infinium Americas OpCo LTD. The details of the transparency notification are set out below and the full text of the transparency notificat...
BioSenic S.A. : Notification de transparence reçue de la part de ABO...
BioSenic S.A. : Notification de transparence reçue de la part de ABO Infinium Americas OpCo LTD. INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes Mont-Saint-Guibert, Belgique, le 7 octobre 2024 à 7h00 CEST – (Euronext Bruxelles et Paris: BIOS), société spécialisée en essais cliniques dans les maladies auto-immunes et inflammatoires graves et la thérapie cellulaire, annonce aujourd’hui la réception de la notification de transparence de ABO Infinium Americas OpCo LTD. Les détails de la notification de transparence sont rep...
BioSenic announces that it has started to look for new assets, the sec...
BioSenic announces that it has started to look for new assets, the securing of its financing for the coming months by means of an amendment to its convertible bond contract, a change to the composition of its board of directors PRIVILEGED INFORMATION Biosenic and Global Tech Opportunities 15 ("GTO 15") have entered into an amendment to the convertible bonds ("CB") agreement securing a further EUR 1.5 million of the programme, including at least two tranches of EUR 0.2 million net each.François Rieger and Véronique Pomi-Schneiter resign from their positions as CEO, chairman and executi...
BioSenic reports half year 2024 results
BioSenic reports half year 2024 results REGULATED INFORMATIONThe interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial instruments admitted to trading on a regulated market and can be accessed on the website of Biosenic in the section ‘Financial reports'. BioSenic publishes its interim financial report in English. A French translation of the report will also be made available. In the event of differences between the English and the French version of the report, the original French version will prevail. Mont-Saint...
BioSenic publie ses résultats pour le premier semestre 2024
BioSenic publie ses résultats pour le premier semestre 2024 INFORMATION REGLEMENTEELe rapport semestriel est préparé conformément à l’article 13 de l’Arrêté Royal relatif aux obligations des émetteurs d’instruments financiers admis à la négociation sur un marché réglementé et peut être consulté sur le site web de BioSenic dans la section ‘Rapports Financiers’. BioSenic publie son rapport financier semestriel en anglais. Une version en français sera également mise à disposition. Si des différences d’interprétation devaient exister entre les versions anglaise et française de ce rapport, la ve...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.